Johnson & Johnson
NYSE: JNJ
$147.03
-$0.74 (-0.5%)
Closing Price on January 17, 2025
JNJ Articles
thinkstockMay 7, 2014: Markets opened higher on Wednesday but it turned into a miserable days for tech stocks and the Nasdaq Composite index. Lack of enthusiasm for momentum stocks pretty much sealed...
Published:
Last Updated:
This past week brought yet another swing taking the Dow Jones Industrial Average to within 30 points or so of an all-time record high. 24/7 Wall St, wanted to review the four best Dow stocks so far...
Published:
In a new research report, RBC adds and deletes names from its Guided Portfolio: Dividend Growth offering. We screened them by sector, looking for the highest yield for income-oriented investors.
Published:
thinkstockApril 15, 2014: Markets opened slightly higher on Tuesday with shares moving up before bouncing down after headlines related to confrontations in Ukraine. By afternoon markets had recovered...
Published:
Last Updated:
Johnson & Johnson reported better-than-expected first-quarter results before markets opened Tuesday morning. And the company boosted its earnings guidance for the full year.
Published:
Last Updated:
ThinkstockWhen Automatic Data Processing Inc. (NYSE: ADP) announced on Thursday that it would spin off its dealer services business, it didn’t take long for the credit ratings agencies to swing...
Published:
Last Updated:
ThinkstockThe more the market gets hit, the more people stare at their portfolios and wonder what would be the best additions. We frequently update the UBS Dividend Ruler stocks list, and now may be...
Published:
courtesy of The Coca-Cola CompanyOne of the world’s most recognized brand — The Coca-Cola Co. (NYSE: KO) — topped a new list of the world’s most powerful brands. The soft drink was followed...
Published:
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about the toppy market may want...
Published:
Shares of Dendreon moved higher Monday after the biotech company said it will start to market Provenge, its prostate-cancer drug, in Europe this year. Its fourth-quarter loss was smaller than...
Published:
Shares of biotechnology company Anika Therapeutics soared to an all-time high Wednesday after the company said the FDA had approved its drug to treat pain and improve joint mobility in patients with...
Published:
White House Photo by Pete SouzaAs many consider Warren Buffett to be the greatest investor of modern times, investors want to know any time there are big changes in the Berkshire Hathaway Inc. (NYSE:...
Published:
The UBS team thinks that investors that take "flight to safety" into U.S. treasury bonds and defensive, high dividend yield equities could get hurt bad later in the year. In a new research report,...
Published:
The top equity strategist at Merrill Lynch has updated the High Quality and Dividend Yield screen of stocks to buy, adding some names that may provide investors solid 2014 returns.
Published:
Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) is out with its fourth-quarter earnings report. The pharma and consumer products giant is a key Dow Jones Industrial Average component, and shares...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.